<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated">
      <PMID Version="1">35248410</PMID>
      <DateCompleted>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2022</Year>
        <Month>05</Month>
        <Day>20</Day>
      </DateRevised>
      <Article PubModel="Print-Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1532-8171</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>56</Volume>
            <PubDate>
              <Year>2022</Year>
              <Month>Jun</Month>
            </PubDate>
          </JournalIssue>
          <Title>The American journal of emergency medicine</Title>
          <ISOAbbreviation>Am J Emerg Med</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Acute transverse myelitis progressing to permanent quadriplegia following COVID-19 infection.</ArticleTitle>
        <Pagination>
          <StartPage>391.e1</StartPage>
          <EndPage>391.e3</EndPage>
          <MedlinePgn>391.e1-391.e3</MedlinePgn>
        </Pagination>
        <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ajem.2022.02.038</ELocationID>
        <ELocationID EIdType="pii" ValidYN="Y">S0735-6757(22)00123-1</ELocationID>
        <Abstract>
          <AbstractText>As of January 2022, there have been over 350 million confirmed cases of COVID-19 in the world. The most common symptoms in those infected are fever, cough, malaise, and myalgia, however pulmonary, hematologic, gastrointestinal, renal, and neurologic complications have also been reported. Acute transverse myelitis (ATM) is an uncommon neurological syndrome characterized by acute or subacute spinal cord dysfunction that can lead to paresthesias, sensory and autonomic impairment, and even paralysis. Etiologies are often unclear; however, potential causes include infection, neoplastic, drug or toxin induced, autoimmune, and acquired. Treatment for ATM primarily consists of steroids and plasmapheresis, which often reverses any neurologic symptoms. ATM has rarely been reported as a complication of COVID-19 infections. A 43-year-old female presented to the emergency department for evaluation of progressive numbness and tingling in her legs ten days after developing upper respiratory symptoms from a COVID-19 infection. Physical examination and magnetic resonance imaging confirmed a diagnosis of ATM. During her hospital course, she experienced rapid progression of her paresthesias and developed complete loss of motor function in her upper and lower extremities. Within 48 hours after emergency department arrival, she required intubation due to worsening diaphragmatic and chest wall paralysis. Her treatment included a long-term steroid regimen and plasmapheresis, and unfortunately, she did not have any neurologic recovery. We present a very rare case of ATM progressing to complete quadriplegia following COVID-19 infection.</AbstractText>
          <CopyrightInformation>Copyright Â© 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Prete</LastName>
            <ForeName>Spencer</ForeName>
            <Initials>S</Initials>
            <AffiliationInfo>
              <Affiliation>Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, United States of America; Northeast Ohio Medical University, Rootstown, OH, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>McShannic</LastName>
            <ForeName>Joseph D</ForeName>
            <Initials>JD</Initials>
            <AffiliationInfo>
              <Affiliation>Northeast Ohio Medical University, Rootstown, OH, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Fertel</LastName>
            <ForeName>Baruch S</ForeName>
            <Initials>BS</Initials>
            <AffiliationInfo>
              <Affiliation>Emergency Services Institute Cleveland Clinic Foundation, Enterprise Quality and Safety, Cleveland Clinic Lerner College of Medicine, Cleveland, OH, United States of America.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Simon</LastName>
            <ForeName>Erin L</ForeName>
            <Initials>EL</Initials>
            <AffiliationInfo>
              <Affiliation>Cleveland Clinic Akron General, Department of Emergency Medicine, Akron, OH, United States of America; Northeast Ohio Medical University, Rootstown, OH, United States of America. Electronic address: SimonE@ccf.org.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D002363">Case Reports</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2022</Year>
          <Month>02</Month>
          <Day>23</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Am J Emerg Med</MedlineTA>
        <NlmUniqueID>8309942</NlmUniqueID>
        <ISSNLinking>0735-6757</ISSNLinking>
      </MedlineJournalInfo>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009188" MajorTopicYN="Y">Myelitis, Transverse</DescriptorName>
          <QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D010292" MajorTopicYN="N">Paresthesia</DescriptorName>
          <QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D011782" MajorTopicYN="N">Quadriplegia</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">COVID-19</Keyword>
        <Keyword MajorTopicYN="N">Quadraplegia</Keyword>
        <Keyword MajorTopicYN="N">Transverse myelitis</Keyword>
      </KeywordList>
      <CoiStatement>Declaration of Competing Interest The authors have no conflicts of interest to disclose.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>2</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>11</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2022</Year>
          <Month>2</Month>
          <Day>14</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2022</Year>
          <Month>5</Month>
          <Day>21</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2022</Year>
          <Month>3</Month>
          <Day>6</Day>
          <Hour>20</Hour>
          <Minute>27</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>ppublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">35248410</ArticleId>
        <ArticleId IdType="pmc">PMC8864811</ArticleId>
        <ArticleId IdType="doi">10.1016/j.ajem.2022.02.038</ArticleId>
        <ArticleId IdType="pii">S0735-6757(22)00123-1</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>World Health Organization . World Health Organization; January 26, 2022. WHO Coronavirus (COVID-19) dashboard.https://covid19.who.int/ Retrieved from.</Citation>
        </Reference>
        <Reference>
          <Citation>Fumery T., Baudar C., Ossemann M., London F. Longitudinally extensive transverse myelitis following acute COVID-19 infection. Mult Scler Relat Disord. 2021;48 doi: 10.1016/j.msard.2020.102723.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.msard.2020.102723</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arslan D., Acar-Ozen P., Gocmen R., Elibol B., Karabudak R., Tuncer A. Post-COVID-19 longitudinally extensive transverse myelitis: is it a new entity? Neurol Sci. November 24, 2021 doi: 10.1007/s10072-021-05640-1. Published online.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10072-021-05640-1</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kara S., Candelore T., Youssef P., Nedd K. Evidence of post-COVID-19 transverse myelitis demyelination. Cureus. October 27, 2021 doi: 10.7759/cureus.19087. Published online.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7759/cureus.19087</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Portela-SÃ¡nchez S., SÃ¡nchez-Soblechero A., Melgarejo Otalora P.J., et al.  Neurological complications of COVID-19 in hospitalized patients: the registry of a neurology department in the first wave of the pandemic. Eur J Neurol. 2021;28(10):3339â3347. doi: 10.1111/ene.14748.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14748</ArticleId>
            <ArticleId IdType="pmc">PMC8013314</ArticleId>
            <ArticleId IdType="pubmed">33474816</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Beh S.C., Greenberg B.M., Frohman T., Frohman E.M. Transverse myelitis. Neurol Clin. 2013;31(1):79â138. doi: 10.1016/j.ncl.2012.09.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ncl.2012.09.008</ArticleId>
            <ArticleId IdType="pmc">PMC7132741</ArticleId>
            <ArticleId IdType="pubmed">23186897</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roy D., Ghosh R., Dubey S., Dubey M.J., Benito-LeÃ³n J., Kanti Ray B. Neurological and neuropsychiatric impacts of COVID-19 pandemic. Can J Neurol Sci. 2021;48(1):9â24. doi: 10.1017/cjn.2020.173.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/cjn.2020.173</ArticleId>
            <ArticleId IdType="pmc">PMC7533477</ArticleId>
            <ArticleId IdType="pubmed">32753076</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Schulte E.C., Hauer L., Kunz A.B., Sellner J. Systematic review of cases of acute myelitis in individuals with COVID-19. Eur J Neurol. 2021;28(10):3230â3244. doi: 10.1111/ene.14952.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ene.14952</ArticleId>
            <ArticleId IdType="pmc">PMC8239542</ArticleId>
            <ArticleId IdType="pubmed">34060708</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
